JPS63246665A - Stabilization of reagent for measuring biological component - Google Patents
Stabilization of reagent for measuring biological componentInfo
- Publication number
- JPS63246665A JPS63246665A JP28595786A JP28595786A JPS63246665A JP S63246665 A JPS63246665 A JP S63246665A JP 28595786 A JP28595786 A JP 28595786A JP 28595786 A JP28595786 A JP 28595786A JP S63246665 A JPS63246665 A JP S63246665A
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- peroxidase
- catalase
- oxidase
- measuring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 88
- 230000006641 stabilisation Effects 0.000 title description 3
- 238000011105 stabilization Methods 0.000 title description 3
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 29
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 29
- 102000016938 Catalase Human genes 0.000 claims abstract description 13
- 108010053835 Catalase Proteins 0.000 claims abstract description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 17
- 230000001590 oxidative effect Effects 0.000 claims description 9
- 102000004316 Oxidoreductases Human genes 0.000 claims description 5
- 108090000854 Oxidoreductases Proteins 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 abstract description 7
- 102000004190 Enzymes Human genes 0.000 abstract description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract description 4
- 239000003381 stabilizer Substances 0.000 abstract description 4
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 abstract description 2
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 abstract description 2
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 abstract description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 abstract description 2
- 239000005516 coenzyme A Substances 0.000 abstract description 2
- 229940093530 coenzyme a Drugs 0.000 abstract description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 abstract description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract description 2
- 102000004539 Acyl-CoA Oxidase Human genes 0.000 abstract 2
- 108020001558 Acyl-CoA oxidase Proteins 0.000 abstract 2
- 230000003647 oxidation Effects 0.000 abstract 2
- 238000007254 oxidation reaction Methods 0.000 abstract 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 abstract 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 abstract 1
- 239000000975 dye Substances 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- -1 methylbenzthiazolone hydrazone Chemical class 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000852 hydrogen donor Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000057621 Glycerol kinases Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 101710163410 Probable glycerol kinase Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- KFGJICJPSZZEEP-UHFFFAOYSA-L dipotassium;hydrogen phosphate;hydrate Chemical compound O.[K+].[K+].OP([O-])([O-])=O KFGJICJPSZZEEP-UHFFFAOYSA-L 0.000 description 1
- 239000000386 donor Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 108010054790 glycerol-3-phosphate oxidase Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野1
本発明は、酸化酵素の反応を利用した2試薬系の生体成
分測定用試薬の盲検値(ブランク)の低下・安定化をは
かるものであり、主として臨床診断薬の品質の向上に役
立てるものである。[Detailed Description of the Invention] [Industrial Application Field 1] The present invention aims to reduce and stabilize the blind value (blank) of a two-reagent system reagent for measuring biological components using the reaction of oxidase. It is mainly used to improve the quality of clinical diagnostic reagents.
[従来の技術]
現在まで、生体成分を測定する試薬、例えば血清中の遊
離脂肪酸、トリグリセライド、コレステロール、尿酸、
グルコース等を測定する様々な試薬が開発されている。[Prior Art] Until now, reagents for measuring biological components, such as free fatty acids in serum, triglycerides, cholesterol, uric acid,
Various reagents for measuring glucose and the like have been developed.
特に近年は、#素性が開発され、より短時間により正確
にこれらの物質の測定ができるようになった。酵素法で
は主に測定しようとする生体成分そのものに作用する、
あるいはその生体成分から酵素により二次的に生成した
物質に作用する酸化酵素が用いられる。即ち、酸化酵素
の作朋で生成する過酸化水素を、フェノール系あるいは
アニリン系の適当な水素供与体と4−アミノアンチピリ
ンあるいはメチルベンズチアゾロンヒドラゾン等の適当
な酸化性色素カップラーとでパーオキシダーゼの存在下
発色させ(酸化性色素カップリング反応)、その吸光度
を測定することにより目的の生体成分の測定を行なう。Particularly in recent years, #identification has been developed, making it possible to measure these substances more accurately in a shorter time. Enzymatic methods mainly act on the biological components themselves to be measured.
Alternatively, an oxidizing enzyme that acts on a substance secondarily produced by an enzyme from the biological component is used. That is, hydrogen peroxide produced by the production of oxidase is converted into peroxidase using a suitable phenol-based or aniline-based hydrogen donor and a suitable oxidizing dye coupler such as 4-aminoantipyrine or methylbenzthiazolone hydrazone. The biological component of interest is measured by developing color in the presence of the dye (oxidative dye coupling reaction) and measuring its absorbance.
こうした#素性は、1ステツプ法あるいは2ステツプ法
で行なわれており、前者は測定用試薬成分が全部−緒に
なった1試薬系であり、後者は試薬成分を2つにわけた
2試薬系を使う。両方法を比較すると、試薬の安定性あ
るいは測定する試料中に含まれる還元物質の影響を受け
にくい等の点で一般的に2ステツプ法の方が有利である
。These #identifications are performed using a one-step method or a two-step method; the former uses a single reagent system in which all the reagent components for measurement are combined, and the latter uses a two-reagent system in which the reagent components are divided into two. use. When comparing both methods, the two-step method is generally more advantageous in terms of stability of the reagent and less influence by reducing substances contained in the sample to be measured.
[発明が解決しようとする問題点]
しかしながら、2ステツプ法による生体成分測定試薬で
も1ステツプ法と程度の差こそあれ、その保存中に試薬
ブランクの上昇があり、これが大きな問題になる。1ス
テツプ法は1試薬中に発色系の試薬、即ちパーオキシダ
ーゼ、4−7ミノアンチビリン又はメチルベンズチアゾ
ロンヒドラゾン等の酸化性色素カップラー、及びフェノ
ール系又はアニリン系等の水素供与体が共存しているた
め、その試薬の保存中にこれらの色素が容易に酸化を受
けて発色し試薬ブランクが上昇する傾向が強い、一方、
2ステツプ法では2試薬系であるため、発色系の試薬を
酸化性色素カップラーと水系供与体の二つに分離できる
ので原理的には試薬ブランクの上昇はないはずである。[Problems to be Solved by the Invention] However, even with biological component measuring reagents based on the two-step method, reagent blanks rise during storage, although the degree of reagents differs to a certain extent from the one-step method, which poses a major problem. In the one-step method, color-forming reagents, i.e., peroxidase, oxidizing dye couplers such as 4-7 minoantibiline or methylbenzthiazolone hydrazone, and hydrogen donors such as phenol or aniline, coexist in one reagent. Therefore, during storage of the reagent, these dyes are easily oxidized and develop color, which tends to increase the reagent blank.
Since the two-step method uses a two-reagent system, the color-forming reagent can be separated into two, the oxidizing dye coupler and the aqueous donor, so in principle there should be no rise in reagent blanks.
ところが、実際は1ステツプ法よりは軽度であるが徐々
に試薬ブランクが上昇する。However, in reality, the reagent blank gradually rises, although it is milder than in the one-step method.
この上うな2試薬系で試薬ブランクが上昇する問題につ
いて、本発明者らは詳細な検討を重ねた結果、パーオキ
シダーゼを含有していない方の試薬(第1試薬又は第2
試薬)に原因があることをつきとめた。As a result of detailed study by the present inventors regarding the problem of increase in reagent blank in the two-reagent system, we found that the reagent containing no peroxidase (first reagent or second reagent)
It was determined that the cause was the reagent.
本発明の課題は、上記パーオキシダーゼを含有していな
い方の試薬の組成を改善し、測定試薬のブランク上昇を
抑える安定な方法を提供することである。An object of the present invention is to provide a stable method for improving the composition of the above-mentioned peroxidase-free reagent and suppressing blank rise in the measurement reagent.
[問題点を解決するための手段]
本発明は、酸化酵素の作用により生成した過酸化水素を
パーオキシダーゼの存在下、酸化性色素カップリング反
応で比色定量することにより目的の生体成分を測定する
2試薬系の測定用試薬において、パーオキシダーゼを含
有していない方の試薬に、特にパーオキシダーゼ及び/
又はカタラーゼを添加することを特徴とする生体成分の
測定用試薬の安定化法である。[Means for Solving the Problems] The present invention measures a target biological component by colorimetrically quantifying hydrogen peroxide produced by the action of an oxidase in the presence of peroxidase through an oxidative dye coupling reaction. In a two-reagent system measurement reagent, the reagent that does not contain peroxidase is especially
Alternatively, it is a method for stabilizing a reagent for measuring biological components, which is characterized by adding catalase.
本発明を実施するには、2試薬系測定用試薬のうち発色
系試薬の水素供与体と酸化性色素カップラーを第1試薬
と第2試薬に別々になるように処方し、パーオキシダー
ゼを含有していない方の試薬に、安定化剤として特にパ
ーオキシダーゼ又はカタラーゼを添加する。パーオキシ
ダーゼの場合は、結果的に第1試薬と@2試薬の両方に
処方することになる。又、カタラーゼの場合は、パーオ
キシダーゼを含有していない方にのみ添加するか、ある
いは第1試薬、第2試薬両者に添加処方する。To carry out the present invention, the hydrogen donor and oxidative dye coupler of the coloring reagent are separately formulated into the first reagent and the second reagent among the reagents for two-reagent system measurement, and peroxidase is contained. To the other reagent, in particular peroxidase or catalase is added as a stabilizer. In the case of peroxidase, it ends up being prescribed to both the first reagent and the @2 reagent. In the case of catalase, it is added only to the one that does not contain peroxidase, or it is added to both the first reagent and the second reagent.
これに用いるパーオキシダーゼはどのような起源のもの
でもよく、試薬中に0.001 U/yr1以上の濃度
で添加すると着明な効果がみられる。カタラーゼについ
ても起源は問わず添加濃度はI Ulz1以上が望まし
い。The peroxidase used for this purpose may be of any origin, and a clear effect is seen when it is added to the reagent at a concentration of 0.001 U/yr1 or more. Regarding catalase, it is preferable that the concentration of catalase added is at least 1 Ulz1, regardless of its origin.
本発明において過酸化水素を生成させる酸化酵素試薬と
は、目的の生体成分測定に対応し、アシルフエンザイム
Aオキシグーゼ、グリセリン−3−リン酸オキシグーゼ
、グルコースオキシダーゼ、コレステロールオキシグー
ゼ、ウリカーゼ等をさし示す。In the present invention, the oxidase reagent that generates hydrogen peroxide corresponds to the target biological component measurement, and includes acylphenzyme A oxygase, glycerin-3-phosphate oxygase, glucose oxidase, cholesterol oxygase, uricase, etc. Show.
発色系試薬の水素供与体としては、7工7−ル系化合物
又はアニリン系化合物の公知のものを用い、酸化性色素
カップラーとしては、4−アミ/アンチピリン又はメチ
ルベンズチアゾロンヒドラゾンを用いることができる。As the hydrogen donor of the color-forming reagent, a known 7-ol compound or aniline compound can be used, and as the oxidizing dye coupler, 4-amino/antipyrine or methylbenzthiazolone hydrazone can be used. can.
本発明は、実質的i二どんな緩衝剤を含む生体成分測定
用試薬においても有効である。一般的にはpH4〜9の
範囲であり、リン酸、トリス、P工PES、HEPES
、)リシン、グリシン等の公知の緩衝剤が用いられる。The present invention is also effective in reagents for measuring biological components containing substantially any buffering agent. Generally, the pH is in the range of 4 to 9, and phosphoric acid, Tris, PES, HEPES
, ) Known buffering agents such as lysine and glycine are used.
[作用効果]
各種生体成分を測定する2試薬系の測定用試薬において
、パーオキシダーゼを含有していない方の試薬に、パー
オキシダーゼ或いはカタラーゼを添加することにより、
試薬ブランクの経時的な上昇を防止することが可能にな
った。[Effect] In a two-reagent system measuring reagent for measuring various biological components, by adding peroxidase or catalase to the reagent that does not contain peroxidase,
It is now possible to prevent the reagent blank from increasing over time.
以下、実施例により本発明を詳細に示す。Hereinafter, the present invention will be illustrated in detail with reference to Examples.
実施例1
遊離脂肪酸測定用試薬の安定化法
(1)試薬の調製
■試薬1
50mMリン酸二水索カリツムー水酸化カリウムt&W
B fL(pH7,0)に7シルコエンザイムAシンセ
ターゼ0.4U/xi、コエンザイムA 0.3mM
。Example 1 Stabilization method of reagent for measuring free fatty acids (1) Preparation of reagent ■Reagent 1 50mM potassium hydroxide t&W
B fL (pH 7,0) with 7silcoenzyme A synthetase 0.4 U/xi, coenzyme A 0.3 mM
.
A T P 1.5mM、 4−アミノアンチピリン2
a+M。ATP 1.5mM, 4-aminoantipyrine 2
a+M.
塩化マグネシウム1mMを含有する溶液を調製し、これ
に安定化剤としてパーオキシダーゼをIU/ x(l又
はカタラーゼを100U/Mとなるように加える。これ
を第1試薬として、遮光容器中、2〜8℃で7日間保存
する。Prepare a solution containing 1 mM of magnesium chloride, and add peroxidase as a stabilizer at IU/x (l) or catalase at 100 U/M. Use this as the first reagent in a light-tight container for 2 to 30 minutes. Store at 8°C for 7 days.
■試薬2
10mMリン酸二水素カリウム−水酸化カリウム緩衝液
(pH7,0)に7シルコエンザイムAオキシグーゼ5
U/xl、FAD 3μM、 N−エチルマレイミド1
mM、パーオキシダーゼ4U/xi、N−エチル−N−
(2−ヒドロキシ−3−スルホプロピル)m−)ルイノ
ン3mMを含有する溶液を調製する。これを第2試薬と
して遮光容器中、2〜8℃で7日間保存する。■Reagent 2 7silcoenzyme A oxyguse 5 in 10mM potassium dihydrogen phosphate-potassium hydroxide buffer (pH 7.0)
U/xl, FAD 3μM, N-ethylmaleimide 1
mM, peroxidase 4U/xi, N-ethyl-N-
A solution containing 3mM of (2-hydroxy-3-sulfopropyl)m-)ruinone is prepared. This is stored as a second reagent in a light-shielded container at 2 to 8°C for 7 days.
(2)測定操作
精製水0.05+Nに試薬1を1.Oif加えて、37
℃で5分間放置し、次いで試薬2を2.OR1加えて3
7°Cで5分間反応後、吸光度を555nmで測定する
。(水を対照)
比較例1
実施例1の試薬1におけるパーオキシダーゼ又はカタラ
ーゼのみ除いて、他は全く同一の試薬1.2を調製し、
操作法についても実施例1と同様とする。(2) Measurement procedure Add reagent 1 to 0.05+N purified water. Oif plus 37
℃ for 5 minutes, then add reagent 2 to 2. OR1 plus 3
After reaction for 5 minutes at 7°C, absorbance is measured at 555 nm. (Water as a control) Comparative Example 1 Reagent 1.2 was prepared which was completely the same as in Reagent 1 of Example 1 except for peroxidase or catalase, and
The operating method is also the same as in Example 1.
(3)結果
第1表に示した通り、パーオキシダーゼ或いはカタラー
ゼをパーオキシダーゼを含んでいない第1試薬に添加す
ることにより、試薬ブランクの上昇が者しく抑えられた
。(3) Results As shown in Table 1, by adding peroxidase or catalase to the first reagent not containing peroxidase, the increase in the reagent blank was clearly suppressed.
第1表
半 CAT :カタラーゼ、POD :パーオキシグー
ゼ辛豪第1、第2試薬の保存期間
実施例2
トリグリセライド測定用試薬の安定化法(1)試薬の調
製
■試薬1
20mMPIPES−水酸化ナトリウム緩衝液(pH7
,0)にグリセロール−3−リン酸オキシダーゼ6U/
xi、グリセロキナーゼ0.5 U/x1、AT P
1,5mM 、塩化マグネシラA 20mM、 パーオ
キシダーゼ3U/all SN −(2−カルボキシエ
チル)−N−エチル−ra−)ルイジン2mM ヲt
有t ル溶液を調製する。これを第1試薬として、遮光
容器中、2〜8℃で30日間保存する。Table 1 and a half CAT: Catalase, POD: Peroxyguze Xinhao 1st and 2nd reagent storage period Example 2 Stabilization method of triglyceride measurement reagent (1) Preparation of reagent ■Reagent 1 20mM PIPES-sodium hydroxide buffer ( pH7
, 0) with 6 U of glycerol-3-phosphate oxidase/
xi, glycerokinase 0.5 U/x1, ATP
1.5mM, magnesilla chloride A 20mM, peroxidase 3U/all SN-(2-carboxyethyl)-N-ethyl-ra-)luidine 2mM
Prepare a complete solution. This is used as the first reagent and stored in a light-shielded container at 2 to 8°C for 30 days.
■試薬2
20mM P I P E S−水酸化ナトリウム緩衝
液(pH7,0)にリポプロティンリパーゼ500U/
zf。■Reagent 2 Lipoprotein lipase 500U/20mM PIPES-sodium hydroxide buffer (pH 7.0)
zf.
4−7ミノアンチピリン1,5mMを含有する溶液を調
製し、これに安定化剤としてパーオキシダーゼを0.
I U/z(lどなるように加える。これを第2試薬と
して遮光容器中、2〜8℃で30日間保存する。A solution containing 1.5mM of 4-7 minoantipyrine was prepared, and 0.0% of peroxidase was added as a stabilizer to this solution.
Add IU/z (1) as the second reagent and store it in a light-tight container at 2-8°C for 30 days.
(2)測定操作
精製水0.02xIに試薬1を1.5x1加乏で、37
°Cで5分間放置し、次いで試薬2を1.5xl加えて
37℃で5分間反応後、吸光度を550nmで測定する
。(水を対照)
比較例2
実施例2の試薬2におけるパーオキシダーゼのみ除いて
、他は全く同一の試薬1.2を調製し、操作法について
も実施例2と同様とする。(2) Measurement procedure Add 1.5x1 of reagent 1 to 0.02xI of purified water, 37
The mixture was allowed to stand for 5 minutes at °C, then 1.5xl of Reagent 2 was added, and after reacting at 37 °C for 5 minutes, the absorbance was measured at 550 nm. (Water as a control) Comparative Example 2 Reagent 1.2, which is completely the same except for peroxidase in Reagent 2 of Example 2, is prepared, and the procedure is the same as in Example 2.
(3)結果
第2表に示した通り、パーオキシダーゼを含んでいない
第2試薬にパーオキシダーゼを添加することにより、試
薬ブランクの安定性が着しく向上した。 。(3) Results As shown in Table 2, the stability of the reagent blank was significantly improved by adding peroxidase to the second reagent that did not contain peroxidase. .
第2表Table 2
Claims (1)
ダーゼの存在下、酸化性色素カップリング反応で比色定
量することにより目的の生体成分を測定する2試薬系の
測定用試薬において、パーオキシダーゼを含有していな
い方の試薬に、特にパーオキシダーゼ及び/又はカタラ
ーゼを添加することを特徴とする生体成分測定用試薬の
安定化法。Contains peroxidase in a two-reagent measuring reagent that measures target biological components by colorimetrically quantifying hydrogen peroxide produced by the action of oxidase in the presence of peroxidase using an oxidative dye coupling reaction. 1. A method for stabilizing a reagent for measuring biological components, which comprises adding peroxidase and/or catalase to the other reagent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61285957A JP2562882B2 (en) | 1986-12-02 | 1986-12-02 | Stabilization method of reagents for measuring biological components |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61285957A JP2562882B2 (en) | 1986-12-02 | 1986-12-02 | Stabilization method of reagents for measuring biological components |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30047895A Division JP2663257B2 (en) | 1995-10-26 | 1995-10-26 | Method for stabilizing reagent for measuring biological components |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63246665A true JPS63246665A (en) | 1988-10-13 |
JP2562882B2 JP2562882B2 (en) | 1996-12-11 |
Family
ID=17698143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61285957A Expired - Lifetime JP2562882B2 (en) | 1986-12-02 | 1986-12-02 | Stabilization method of reagents for measuring biological components |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2562882B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010090030A1 (en) * | 2009-02-06 | 2010-08-12 | 積水メディカル株式会社 | Blank sample |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52117695A (en) * | 1976-03-25 | 1977-10-03 | Boehringer Mannheim Gmbh | Measuring method of cholesterine and reagent used in the method |
JPS5438196A (en) * | 1977-09-01 | 1979-03-22 | Kyowa Hakko Kogyo Kk | Quantitative determination of neautral fat in serum and composition therefor |
JPS55120784A (en) * | 1979-02-27 | 1980-09-17 | Greiner & Soehne C A | Inspection test tube for clinical inspection |
JPS5726600A (en) * | 1976-08-19 | 1982-02-12 | Eastman Kodak Co | Method and composition for detecting glycerine |
JPS5818080A (en) * | 1981-07-23 | 1983-02-02 | 松下冷機株式会社 | Refrigerator |
JPS61173799A (en) * | 1985-01-29 | 1986-08-05 | Toyobo Co Ltd | Method of determining activity of substrate or enzyme |
-
1986
- 1986-12-02 JP JP61285957A patent/JP2562882B2/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52117695A (en) * | 1976-03-25 | 1977-10-03 | Boehringer Mannheim Gmbh | Measuring method of cholesterine and reagent used in the method |
JPS5726600A (en) * | 1976-08-19 | 1982-02-12 | Eastman Kodak Co | Method and composition for detecting glycerine |
JPS5438196A (en) * | 1977-09-01 | 1979-03-22 | Kyowa Hakko Kogyo Kk | Quantitative determination of neautral fat in serum and composition therefor |
JPS55120784A (en) * | 1979-02-27 | 1980-09-17 | Greiner & Soehne C A | Inspection test tube for clinical inspection |
JPS5818080A (en) * | 1981-07-23 | 1983-02-02 | 松下冷機株式会社 | Refrigerator |
JPS61173799A (en) * | 1985-01-29 | 1986-08-05 | Toyobo Co Ltd | Method of determining activity of substrate or enzyme |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010090030A1 (en) * | 2009-02-06 | 2010-08-12 | 積水メディカル株式会社 | Blank sample |
JP5718059B2 (en) * | 2009-02-06 | 2015-05-13 | 積水メディカル株式会社 | Blank sample |
Also Published As
Publication number | Publication date |
---|---|
JP2562882B2 (en) | 1996-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4543326A (en) | Stabilization of oxidase | |
US4517287A (en) | Method and reagent for the enzymatic determination of enzyme substrates | |
US4368261A (en) | Method and reagent for the determination of triglycerides | |
JP6446875B2 (en) | Biological component measuring method and measuring composition | |
JP6569193B2 (en) | Biological component measuring method and measuring composition | |
JP6435605B2 (en) | Biological component measuring method and measuring composition | |
JP6459268B2 (en) | Biological component measuring method and measuring composition | |
JPS5819279B2 (en) | Method and reagent for measuring NAD(P)H or salicylate | |
EP0121254A2 (en) | Process for determining substrate or enzymatic activity | |
US4695539A (en) | Process for quantitative determination of substrate treated with oxidase | |
EP0100217B1 (en) | Process for quantitative determination of substrate treated with oxidase | |
JPS63246665A (en) | Stabilization of reagent for measuring biological component | |
US5266472A (en) | Stabilization of the enzyme urate oxidase in liquid form | |
US5474908A (en) | Method of enzymatically measuring hydrogen peroxide and reagent therefor | |
JPH07155196A (en) | Method for measuring biological component | |
JP2663257B2 (en) | Method for stabilizing reagent for measuring biological components | |
Smith et al. | Automated measurement of total cholesterol and triglycerides, in" tandem," on the discrete sample analyzer, Gilford System 3500. | |
JP4620881B2 (en) | Method for stabilizing ascorbate oxidase and reagent for measuring biological components | |
JPS61293397A (en) | Composition for detecting triglyceride | |
Okabe et al. | o-Toluoylcholine as substrate for measurement of serum pseudo-cholinesterase activity | |
JPS59159798A (en) | Measurement of humoral components | |
JPS6349081A (en) | Stabilization of ascorbic acid oxidase | |
JP2643205B2 (en) | Highly sensitive colorimetric method | |
JPH0153040B2 (en) | ||
EP0019875A1 (en) | Method for assaying fatty acids |